The global smart drug delivery systems market is expected to see rapid growth in the next few years, reaching $25.94 billion by 2028. This growth can be attributed to factors such as the increasing burden of non-communicable diseases, the rise of precision medicine, and advancements in technology such as AI and IoT. Major companies in the market include Pfizer, Johnson & Johnson, and Bayer AG.